AI Medical Diagnosis App Market By Application , By Deployment Model By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

AI Medical Diagnosis App Market

The AI medical diagnosis app market was valued at $0.9 billion in 2023 and is projected to reach $5.2 billion by 2033, growing at a CAGR of 19.1% from 2024 to 2033.

An AI medical diagnosis app is a software which assists in the diagnosis of medical conditions or provision of medical advice through the utilization of AI and machine learning algorithms. These apps analyze the data and patient history to generate potential diagnoses and offer recommendations. The key attributes of the diagnosis apps include offering personalized solutions for each patient and aid healthcare institutions in providing remote monitoring to their patients.

With increasing requirement for advanced healthcare in remote locations and underserved regions, the demand for AI medical diagnosis app is rising significantly. Furthermore, the shortage of proficient doctors and healthcare providers across the globe is driving the growth of the market as the app mitigates the load by reducing waiting times through the provision of online consultations. To enhance the efficacy and promote telemedicine, developers are designing highly user-friendly applications, in which patients are able to record their disease conditions or body vital. Such apps are fostering the trend of real-time diagnosis and helping the healthcare providers take instant actions.

However, the accuracy of the apps is not entirely reliable, thereby hampering the growth of the AI medical diagnosis app market. In addition, compliance with the ethical and data privacy standards is an intricate and time-consuming process, which restraints market development. Different regulatory bodies such as Health Insurance Portability and Accountability Act in the U.S. and General Data Protection Regulation in Europe have imposed stringent guidelines regarding the collection, storage, and usage of patient data. As per the guidelines, access to patient data is limited to authorized personnel, which is subject to periodic audits to monitor and track the access.

Segment Review

The AI medical diagnosis app market is segmented into application, deployment model, end user, and region. On the basis of application, the market is divided into radiology, pathology, cardiology, dermatology, and other. As per deployment model, it is bifurcated into cloud-based and on-premises. Depending on end user, it is classified into hospitals, diagnostic centers, clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of application, the radiology segment dominates in the AI medical diagnosis app market.

As per deployment model, the cloud-based segment acquires a high share of the market.

Depending on end user, the hospitals segment is the highest shareholder of the AI medical diagnosis app market.

Region wise, North America is the highest revenue generator in the market.

Competition Analysis

The leading players operating in the global AI medical diagnosis app market include Microsoft NVIDIA Corporation, Merative Intel Corporation, Siemens Healthineers, GE HealthCare, Digital Diagnostics Inc., Advanced Micro Devices, Inc, InformAl, HeartFlow, Inc., Enlitic, Inc., icometrix, Aidence, and Butterfly Network, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Average Selling Price Analysis / Price Point Analysis
Historic market data
Reimbursement Scenario

Key Market Segments

By Application

Radiology
Pathology
Cardiology
Dermatology
Other

By Deployment Model

Cloud-based
On-premises

By End User

Hospitals
Diagnostic Centers
Clinics
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

Key Market Players:

Microsoft NVIDIA Corporation
Merative Intel Corporation
Siemens Healthineers
GE HealthCare
Digital Diagnostics Inc.
Advanced Micro Devices, Inc
InformAl
HeartFlow, Inc.
Enlitic, Inc.
icometrix
Aidence
Butterfly Network, Inc.

Product Code: A323964

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: AI MEDICAL DIAGNOSIS APP MARKET, BY APPLICATION

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Application
4.2. Radiology
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Pathology
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. Cardiology
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
4.5. Dermatology
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
4.6. Other
- 4.6.1. Key Market Trends, Growth Factors and Opportunities
- 4.6.2. Market Size and Forecast, By Region
- 4.6.3. Market Share Analysis, By Country

CHAPTER 5: AI MEDICAL DIAGNOSIS APP MARKET, BY DEPLOYMENT MODEL

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Deployment Model
5.2. Cloud-based
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. On-premises
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country

CHAPTER 6: AI MEDICAL DIAGNOSIS APP MARKET, BY END USER

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Diagnostic Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Clinics
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
6.5. Others
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country

CHAPTER 7: AI MEDICAL DIAGNOSIS APP MARKET, BY REGION

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Application
- 7.2.3. Market Size and Forecast, By Deployment Model
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. AI Medical Diagnosis App Market
  - 7.2.6.1. Market Size and Forecast, By Application
  - 7.2.6.2. Market Size and Forecast, By Deployment Model
  - 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada AI Medical Diagnosis App Market
  - 7.2.7.1. Market Size and Forecast, By Application
  - 7.2.7.2. Market Size and Forecast, By Deployment Model
  - 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico AI Medical Diagnosis App Market
  - 7.2.8.1. Market Size and Forecast, By Application
  - 7.2.8.2. Market Size and Forecast, By Deployment Model
  - 7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Application
- 7.3.3. Market Size and Forecast, By Deployment Model
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France AI Medical Diagnosis App Market
  - 7.3.6.1. Market Size and Forecast, By Application
  - 7.3.6.2. Market Size and Forecast, By Deployment Model
  - 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany AI Medical Diagnosis App Market
  - 7.3.7.1. Market Size and Forecast, By Application
  - 7.3.7.2. Market Size and Forecast, By Deployment Model
  - 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy AI Medical Diagnosis App Market
  - 7.3.8.1. Market Size and Forecast, By Application
  - 7.3.8.2. Market Size and Forecast, By Deployment Model
  - 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain AI Medical Diagnosis App Market
  - 7.3.9.1. Market Size and Forecast, By Application
  - 7.3.9.2. Market Size and Forecast, By Deployment Model
  - 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK AI Medical Diagnosis App Market
  - 7.3.10.1. Market Size and Forecast, By Application
  - 7.3.10.2. Market Size and Forecast, By Deployment Model
  - 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest of Europe AI Medical Diagnosis App Market
  - 7.3.11.1. Market Size and Forecast, By Application
  - 7.3.11.2. Market Size and Forecast, By Deployment Model
  - 7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Application
- 7.4.3. Market Size and Forecast, By Deployment Model
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China AI Medical Diagnosis App Market
  - 7.4.6.1. Market Size and Forecast, By Application
  - 7.4.6.2. Market Size and Forecast, By Deployment Model
  - 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan AI Medical Diagnosis App Market
  - 7.4.7.1. Market Size and Forecast, By Application
  - 7.4.7.2. Market Size and Forecast, By Deployment Model
  - 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India AI Medical Diagnosis App Market
  - 7.4.8.1. Market Size and Forecast, By Application
  - 7.4.8.2. Market Size and Forecast, By Deployment Model
  - 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea AI Medical Diagnosis App Market
  - 7.4.9.1. Market Size and Forecast, By Application
  - 7.4.9.2. Market Size and Forecast, By Deployment Model
  - 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia AI Medical Diagnosis App Market
  - 7.4.10.1. Market Size and Forecast, By Application
  - 7.4.10.2. Market Size and Forecast, By Deployment Model
  - 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific AI Medical Diagnosis App Market
  - 7.4.11.1. Market Size and Forecast, By Application
  - 7.4.11.2. Market Size and Forecast, By Deployment Model
  - 7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Application
- 7.5.3. Market Size and Forecast, By Deployment Model
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil AI Medical Diagnosis App Market
  - 7.5.6.1. Market Size and Forecast, By Application
  - 7.5.6.2. Market Size and Forecast, By Deployment Model
  - 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa AI Medical Diagnosis App Market
  - 7.5.7.1. Market Size and Forecast, By Application
  - 7.5.7.2. Market Size and Forecast, By Deployment Model
  - 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia AI Medical Diagnosis App Market
  - 7.5.8.1. Market Size and Forecast, By Application
  - 7.5.8.2. Market Size and Forecast, By Deployment Model
  - 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA AI Medical Diagnosis App Market
  - 7.5.9.1. Market Size and Forecast, By Application
  - 7.5.9.2. Market Size and Forecast, By Deployment Model
  - 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. Microsoft NVIDIA Corporation
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
9.2. Merative Intel Corporation
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
9.3. Siemens Healthineers
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
9.4. GE HealthCare
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
9.5. Digital Diagnostics Inc.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
9.6. Advanced Micro Devices, Inc
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
9.7. InformAl
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
9.8. HeartFlow, Inc.
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
9.9. Enlitic, Inc.
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
9.10. Icometrix
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
9.11. Aidence
- 9.11.1. Company Overview
- 9.11.2. Key Executives
- 9.11.3. Company Snapshot
- 9.11.4. Operating Business Segments
- 9.11.5. Product Portfolio
- 9.11.6. Business Performance
- 9.11.7. Key Strategic Moves and Developments
9.12. Butterfly Network, Inc.
- 9.12.1. Company Overview
- 9.12.2. Key Executives
- 9.12.3. Company Snapshot
- 9.12.4. Operating Business Segments
- 9.12.5. Product Portfolio
- 9.12.6. Business Performance
- 9.12.7. Key Strategic Moves and Developments